M 261
Pill imprint M 261 has been identified as Ketoconazole 200 mg.
Ketoconazole is used in the treatment of vaginal yeast infection; oral thrush; tinea versicolor; onychomycosis, toenail; coccidioidomycosis (and more), and belongs to the drug class azole antifungals. Risk cannot be ruled out during pregnancy.
Ketoconazole 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Ketoconazole Images
- Imprint:
-
M 261
- Strength:
- 200 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
corn starch
- Drug Class:
- Azole antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0261
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43063-0036 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Ketoconazole resources
- Ketoconazole (Wolters Kluwer)
- ketoconazole (Cerner Multum)
- ketoconazole (Micromedex) - Includes Dosage Information
- Ketoconazole (AHFS DI)
- Ketoconazole Tablets (FDA)


